David C. Pryde

3.2k citations

74 papers · 2.3k indexed · h-index 25

Impact in

Sensory Systems top 5%
- Ion Channels and Receptors
Organic Chemistry top 5%
- Catalytic C–H Functionalization Methods
- Catalytic Cross-Coupling Reactions
- Synthetic Organic Chemistry Methods

Papers in

Sensory Systems 5
Physiology 4

Co-authors: David C. Blakemore Thien-Duc Tran Peter Jones Deepak Dalvie Qiyue Hu R. Scott Obach Alan C. Spivey Kiyoyuki Omoto
Journals: Bioorganic & Medicinal Chemistry Letters (6 papers)Journal of Medicinal Chemistry (5 papers)Synlett (4 papers)Tetrahedron Letters (4 papers)Proceedings of the National Academy of Sciences (3 papers)
Partner nations: United Kingdom United States Canada

In The Last Decade

David C. Pryde

70 papers receiving 2.2k citations

Peers

Countries citing papers authored by David C. Pryde

Since Specialization

Citations

This map shows the geographic impact of David C. Pryde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Pryde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Pryde more than expected).

Fields of papers citing papers by David C. Pryde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Pryde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Pryde. The network helps show where David C. Pryde may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David C. Pryde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David C. Pryde Line = papers co-authored together David C. Pryde links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The discovery of potent small molecule cyclic urea activators of STING European Journal of Medicinal Chemistry ·Sourav Basu, X.X. Zhang, 野中康一, Rajib Ghosh, David C. Pryde, Dharmendra B. Yadav, Allen Henkins, Mary L. Allison	2021	8
2	The discovery of potent small molecule activators of human STING European Journal of Medicinal Chemistry ·David C. Pryde, X.X. Zhang, 野中康一, Allen Henkins, Sourav Basu, Rajib Ghosh, Dharmendra B. Yadav, Mary L. Allison	2020	40
3	G10 is a direct activator of human STING PLoS ONE ·野中康一, X.X. Zhang, Allen Henkins, Sourav Basu, Rajib Ghosh, David C. Pryde, Dharmendra B. Yadav, Mary L. Allison	2020	24
4	Valproic acid interactions with the NavMs voltage-gated sodium channel Proceedings of the National Academy of Sciences ·Geancarlo Zanatta, Altin Sula, Andrew J. Miles, Leo Ng, Rubben Torella, David C. Pryde, Paul G. DeCaen, B.A. Wallace	2019	29
5	An Intracellular Allosteric Modulator Binding Pocket in SK2 Ion Channels Is Shared by Multiple Chemotypes Structure ·Shihoko Maeda, Deiseane Matos, Rubben Torella, John D. Knafels, 紀子白水, Johyun Lee, N.V. Tutova, Agnieszka Konopacka, Lone Scherfig, Edward B. Stevens, Julio Roberto González Rios, Reto Horst, Jane M. Withka, David C. Pryde, Shenping Liu, Gareth T. Young	2018	25
6	The discovery of a potent Na_v1.3 inhibitor with good oral pharmacokinetics MedChemComm ·David C. Pryde, Nigel A. Swain, Paul A. Stupple, Christopher W. West, Brian E. Marron, Christopher J. Markworth, David Printzenhoff, Zhiwu Lin, Peter J. Cox, Rie Suzuki, M. Trevisan, Koudai Iwashita, Lucas Furlan Sabbag, Joseph S. Warmus, Mark L. Chapman	2017	6
7	Discovery of a Series of Indazole TRPA1 Antagonists ACS Medicinal Chemistry Letters ·David C. Pryde, Brian E. Marron, Christopher W. West, Antonio Lozano Sánchez, George Amato, G. La Rosa, Brett M. Antonio, Karen Padilla, Mohammad Barqawi, Daniel TA Mati, Joseph S. Warmus, Nigel A. Swain, Kiyoyuki Omoto, John H. Mahoney, Aaron C. Gerlach	2017	19
8	Site-selective Suzuki–Miyaura coupling of heteroaryl halides – understanding the trends for pharmaceutically important classes Chemical Science ·Jagadish Mahadevaiah, David C. Blakemore, David C. Pryde, Alan C. Spivey	2016	156
9	Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs Nature ·Lin Tang, Tamer M. Gamal El-Din, Teresa M. Swanson, David C. Pryde, Todd Scheuer, Ning Zheng, William A. Catterall	2016	151
10	Discovery of a Selective TRPM8 Antagonist with Clinical Efficacy in Cold-Related Pain ACS Medicinal Chemistry Letters ·Mark D. Andrews, J. Bernaud, Kevin Beaumont, Sébastien R. G. Galan, Paul A. Glossop, 高浪洋一, Alan S. Jessiman, Chulwook Kim, W R Hooper, Graham N. Maw, Robert M. Owen, David C. Pryde, Jia Yu, Yong Pu	2015	68
11	A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced‐Fit Pocket Stabilized by a Cation–π Interaction Angewandte Chemie ·Timothy P. C. Rooney, P. Filippakopoulos, O. Fedorov, S. Picaud, Elizabeth W. Patton, Duncan A. Hay, Sarah Martin, Anthony Tumber, Catherine Rogers, Martin Philpott, Minghua Wang, Amber L. Thompson, Tom D. Heightman, David C. Pryde, Andrew S. Cook, Robert S. Paton, Susanne Müller, Stefan Knapp, Paul E. Brennan, Stuart J. Conway	2014	13
12	A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced‐Fit Pocket Stabilized by a Cation–π Interaction Angewandte Chemie International Edition ·Timothy P. C. Rooney, P. Filippakopoulos, O. Fedorov, S. Picaud, Wilian A. Cortopassi, Duncan A. Hay, Sarah Martin, Anthony Tumber, Catherine Rogers, Martin Philpott, Minghua Wang, Amber L. Thompson, Tom D. Heightman, David C. Pryde, Andrew S. Cook, Robert S. Paton, Susanne Müller, Stefan Knapp, Paul E. Brennan, Stuart J. Conway	2014	93
13	Enhancing immunogenicity of a 3′aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates International Immunopharmacology ·Michael J. McCluskie, David C. Pryde, David Gervais, F. de Hauteclòcque, Ningli Zhang, Michelle Benoit, Karen Robertson, In-Jeong Kim, G. Fiore. P. Renno, James Merson, Heather L. Davis	2013	42
14	Selection of a Novel Anti-Nicotine Vaccine: Influence of Antigen Design on Antibody Function in Mice PLoS ONE ·David C. Pryde, Lyn H. Jones, David Gervais, F. de Hauteclòcque, David C. Blakemore, Matthew D. Selby, Alan D. Brown, Jotham W. Coe, Frank Guillermo Intriago Flor, David M. Beal, Rebecca Glen, Volker Luckas, Gavin J. Miller, P. White, Ningli Zhang, Michelle Benoit, Karen Robertson, James Merson, Heather L. Davis, Michael J. McCluskie	2013	66
15	New lithium-zincate approaches for the selective functionalisation of pyrazine: direct dideprotozincation vs. nucleophilic alkylation Chemical Communications ·みずほこうまる, Victoria L. Blair, David C. Blakemore, Duncan A. Hay, Alan R. Kennedy, David C. Pryde, Eva Hevia	2011	43
16	The design and discovery of novel amide CCR5 antagonists Bioorganic & Medicinal Chemistry Letters ·David C. Pryde, Yasmine Echchihab, David R. Fenwick, Helen J. Mason, Ariana C. Goldstein, Peter T. Stephenson, David A. Ellis, 彭可让, David W. Gordon, Chris Barber, Anthony Wood, Donald S. Middleton, David C. Blakemore, A. R. Dubal, Sarah Betty Mupa Mwendar Wallace, Н.М. Старцева, Shu-Hsia Chen, Kirankumar Kumbar, Catherine Burt, Wolfgang Klute	2009	16
17	Targeting the non-structural proteins of hepatitis C virus: beyond hepatitis C virus protease and polymerase Expert Opinion on Drug Discovery ·Tod P. Holler, Tanya Parkinson, David C. Pryde	2009	12
18	Small, non-peptide C5a receptor antagonists: Part 2 Bioorganic & Medicinal Chemistry Letters ·Julian Blagg, Charles E. Mowbray, David C. Pryde, Gary Salmon, David Fairman, Esther F. Schmid, Kevin Beaumont	2008	8
19	Small, non-peptide C5a receptor antagonists: Part 1 Bioorganic & Medicinal Chemistry Letters ·Julian Blagg, Charles E. Mowbray, David C. Pryde, Gary Salmon, Esther F. Schmid, David Fairman, Kevin Beaumont	2008	16
20	Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder Bioorganic & Medicinal Chemistry ·David C. Pryde, Andrew S. Cook, Žana Božić-Gauk, Lyn H. Jones, Habib Jouber, Н.М. Старцева, K A Somanna, Yasmine Echchihab, Alan Stobie, Donald S. Middleton, Qingzhong Ren, Martins Vershima Tolough & Dr. Shidi Hungwa, Bustamante M. Roberto, Peter Stacey, Christopher Kohl, Sara Coggon, Kevin Beaumont	2006	16

About David C. Pryde

David C. Pryde is a scholar working on Sensory Systems, Physiology, Virology, Cellular and Molecular Neuroscience and Infectious Diseases, having authored 74 papers that have together received 2.3k indexed citations. Recurring topics across this work include Ion channel regulation and function (10 papers), interferon and immune responses (8 papers), Biochemical and Molecular Research (8 papers), HIV/AIDS drug development and treatment (8 papers), Synthetic Organic Chemistry Methods (8 papers), Neuroscience and Neuropharmacology Research (7 papers), Nicotinic Acetylcholine Receptors Study (7 papers) and Carbohydrate Chemistry and Synthesis (6 papers). The work is most often cited by research in Sensory Systems (139 citations), Organic Chemistry (689 citations), Pharmacology (170 citations), Cellular and Molecular Neuroscience (333 citations) and Molecular Biology (1.1k citations). David C. Pryde has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include David C. Blakemore, Thien-Duc Tran, Peter Jones, Deepak Dalvie, Qiyue Hu, R. Scott Obach, Alan C. Spivey, Kiyoyuki Omoto, Robert M. Owen and Ben S. Sidders. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Synlett, Tetrahedron Letters and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact